-+ 0.00%
-+ 0.00%
-+ 0.00%

PDS Biotechnology Q4 EPS $(0.14) Beats $(0.20) Estimate

Benzinga·03/30/2026 13:41:03
Listen to the news
PDS Biotechnology (NASDAQ:PDSB) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.20) by 30 percent. This is a 33.33 percent increase over losses of $(0.21) per share from the same period last year.